Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$37.88 - $43.77 $13,295 - $15,363
-351 Reduced 6.43%
5,106 $218,000
Q4 2023

Feb 06, 2024

SELL
$31.71 - $38.95 $10,686 - $13,126
-337 Reduced 5.82%
5,457 $210,000
Q3 2023

Nov 03, 2023

BUY
$37.32 - $49.29 $39,820 - $52,592
1,067 Added 22.57%
5,794 $218,000
Q2 2023

Aug 04, 2023

SELL
$39.98 - $47.68 $18,470 - $22,028
-462 Reduced 8.9%
4,727 $215,000
Q1 2023

May 01, 2023

SELL
$37.58 - $52.57 $61,781 - $86,425
-1,644 Reduced 24.06%
5,189 $210,000
Q4 2022

Feb 07, 2023

BUY
$49.7 - $57.71 $60,137 - $69,829
1,210 Added 21.52%
6,833 $348,000
Q3 2022

Nov 03, 2022

SELL
$53.86 - $66.8 $8,079 - $10,020
-150 Reduced 2.6%
5,623 $303,000
Q2 2022

Aug 02, 2022

SELL
$63.83 - $80.0 $102,957 - $129,040
-1,613 Reduced 21.84%
5,773 $371,000
Q1 2022

May 09, 2022

SELL
$76.85 - $89.45 $22,209 - $25,851
-289 Reduced 3.77%
7,386 $573,000
Q4 2021

Jan 26, 2022

BUY
$74.57 - $87.19 $76,359 - $89,282
1,024 Added 15.4%
7,675 $659,000
Q3 2021

Nov 05, 2021

SELL
$73.77 - $83.61 $9,368 - $10,618
-127 Reduced 1.87%
6,651 $535,000
Q2 2021

Aug 13, 2021

SELL
$80.5 - $88.01 $77,682 - $84,929
-965 Reduced 12.46%
6,778 $546,000
Q1 2021

May 10, 2021

SELL
$76.38 - $86.03 $121,367 - $136,701
-1,589 Reduced 17.03%
7,743 $653,000
Q4 2020

Feb 05, 2021

BUY
$75.39 - $82.36 $114,517 - $125,104
1,519 Added 19.44%
9,332 $749,000
Q3 2020

Nov 09, 2020

SELL
$78.33 - $90.73 $2,036 - $2,358
-26 Reduced 0.33%
7,813 $628,000
Q2 2020

Jul 31, 2020

BUY
$78.66 - $94.14 $20,215 - $24,193
257 Added 3.39%
7,839 $675,000
Q1 2020

Apr 24, 2020

BUY
$71.57 - $93.3 $23,117 - $30,135
323 Added 4.45%
7,582 $615,000
Q4 2019

Feb 07, 2020

BUY
$76.7 - $88.45 $209,391 - $241,468
2,730 Added 60.28%
7,259 $607,000
Q3 2019

Nov 06, 2019

BUY
$81.4 - $89.78 $16,117 - $17,776
198 Added 4.57%
4,529 $396,000
Q2 2019

Aug 06, 2019

SELL
$73.44 - $82.41 $7,197 - $8,076
-98 Reduced 2.21%
4,331 $355,000
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $6,770 - $8,537
-105 Reduced 2.32%
4,429 $361,000
Q4 2018

Feb 08, 2019

SELL
$61.45 - $77.8 $18,803 - $23,806
-306 Reduced 6.32%
4,534 $298,000
Q3 2018

Nov 06, 2018

SELL
$70.71 - $77.75 $13,647 - $15,005
-193 Reduced 3.83%
4,840 $373,000
Q2 2018

Aug 08, 2018

BUY
$63.43 - $75.41 $1,268 - $1,508
20 Added 0.4%
5,033 $372,000
Q1 2018

May 09, 2018

SELL
$62.56 - $72.26 $312,737 - $361,227
-4,999 Reduced 49.93%
5,013 $326,000
Q4 2017

Feb 13, 2018

BUY
$61.45 - $66.05 $318,249 - $342,072
5,179 Added 107.16%
10,012 $647,000
Q3 2017

Oct 31, 2017

BUY
$59.5 - $64.61 $25,525 - $27,717
429 Added 9.74%
4,833 $303,000
Q2 2017

Aug 07, 2017

BUY
N/A
4,404
4,404 $267,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.